Real ChatGPT answer · index seedi819MDBg0jscompleteHealth and wellness · women's healthinformational
What are the current medical guidelines regarding the cardiovascular risks of starting hormone replacement therapy after age fifty five or ten years post menopause?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the current medical guidelines regarding the cardiovascular risks of starting hormone replacement therapy after age fifty five or ten years post menopause?
4 real searches · 1 real-search pass
2026 clinical guidelines starting menopausal hormone therapy after age 60 more than 10 years since menopause cardiovascular risk NAMS ACOG AHAGoogle ↗
OBSERVED
The Menopause Society 2022 hormone therapy position statement timing hypothesis cardiovascular disease 10 years menopause officialGoogle ↗
OBSERVED
ACOG hormone therapy cardiovascular disease not for prevention age 60 10 years menopause officialGoogle ↗
OBSERVED
North American Menopause Society 2025 2026 hormone therapy cardiovascular risk guidelines late initiationGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 4 queries…
Searches and sources
ChatGPT4 real searches · gpt-6
2026 clinical guidelines starting menopausal hormone therapy after age 60 more than 10 years since menopause cardiovascular risk NAMS ACOG AHA Google ↗
The Menopause Society 2022 hormone therapy position statement timing hypothesis cardiovascular disease 10 years menopause official Google ↗
ACOG hormone therapy cardiovascular disease not for prevention age 60 10 years menopause official Google ↗
North American Menopause Society 2025 2026 hormone therapy cardiovascular risk guidelines late initiation Google ↗
- ACOG Clinical Practice Guideline: Management of... : Obstetrics & Gynecology · doi.org
- ACOG Clinical Practice Guideline: Management of... : Obstetrics & Gynecology · doi.org
- The 2022 hormone therapy position statement of The North American Menopause Society · pubmed.ncbi.nlm.nih.gov
- NAMS Hormone Therapy Position Statement 2022 Guideline Summary · guidelinecentral.com
- NAMS 2022 Hormone Therapy Position Statement · menopause.org.au
- VA/DOD CLINICAL PRACTICE GUIDELINE FOR MENOPAUSE · healthquality.va.gov
- Hormone therapy safety · womenshealth.gov
Queries
4 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2026 clinical guidelines starting menopausal hormone therapy after age 60 more than 10 years since menopause cardiovascular risk NAMS ACOG AHA OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
The Menopause Society 2022 hormone therapy position statement timing hypothesis cardiovascular disease 10 years menopause official OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
ACOG hormone therapy cardiovascular disease not for prevention age 60 10 years menopause official OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
North American Menopause Society 2025 2026 hormone therapy cardiovascular risk guidelines late initiation OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |